The treatment of hereditary angio-oedema with low dose androgenic drugs [proceedings].
D000799:Angioedema / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D003174:Complement C1 Inactivator Proteins / Q000378:metabolism; D003613:Danazol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use; D045165:Testosterone Congeners / Q000627:therapeutic use*
D003174:Complement C1 Inactivator Proteins; D045165:Testosterone Congeners; D008696:Methandrostenolone; D003613:Danazol